Published in Pharma Investments, Ventures and Law Weekly, February 26th, 2006
According to recent research from Germany, "The purpose of the study was to examine the morphology and biomechanical characteristics of in vivo cultured tissue-engineered human septal cartilage as a prospective autogenous transplant material for subcutaneous implantation in reconstructive procedures. Chondrocytes were enzymatically isolated from human septal cartilage biopsies."
"The cell number was expanded in monolayer culture. Chondrocytes were then fixed on a nonwoven poly-lactide-poly-glycolide (PGLA) polymer scaffold by means of fibrin glue. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.